ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00669565
Recruitment Status : Completed
First Posted : April 30, 2008
Last Update Posted : March 24, 2011
Sponsor:
Information provided by:
Peregrine Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2010
  Actual Study Completion Date : August 2010